Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Carmel Celestin, MD, is a Staff Physician in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Vascular Medicine. She began her appointment as a Fellow in the Tomsich Family Department of Cardiovascular in 2006. She is board-certified in internal medicine and licensed to practice in both Massachusetts and Ohio. Dr. Celestin's specialty interests include lower-extremity edema, peripheral arterial disease, upper-extremity disorders, Raynaud's and hypercoagulable states.
Dr. Celestin received her medical degree from Howard University College of Medicine, Washington, D.C., in 2002. Her undergraduate degree was obtained from Rutgers University, Newark, N.J., where she was a James Dickson Carr Scholar. Her postgraduate training includes a residency in internal medicine at Baystate Medical Center, an affiliate of Tufts University, in Springfield, Mass. There she became Chief Resident in the Internal Medicine Program while at the same time working as a Hospitalist and as Medical Director of the Change of Heart Program. She received an Excellence In Teaching award from Baystate Medical Center in 2003.
Dr. Celestin has been published in peer-reviewed medical journals. Her research has focused on myocardial infarction, deep vein thrombosis and pulmonary embolism. Additionally, her areas of expertise include treatment for blood clotting disorders, carotid and renal artery disease, lymphedema and abdominal aortic aneurysm.
Dr. Celestin has contributed her time to local civic activities such as mentoring high school students and volunteering at a free clinic. On an international level, she has participated in community outreach programs in Costa Rica and Cuba. She speaks both Spanish and French Creole.
Lower extremity edema, peripheral arterial disease, upper extremity disorders, minority and women's health care initiatives, raynaud's, hypercoagulable states
Society for Vascular Medicine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/9/2015, Dr. Celestin has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.